WallStSmart

Dell Technologies Inc (DELL)vsEli Lilly and Company (LLY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Dell Technologies Inc generates 57% more annual revenue ($113.54B vs $72.25B). LLY leads profitability with a 35.0% profit margin vs 5.2%. DELL appears more attractively valued with a PEG of 0.87. LLY earns a higher WallStSmart Score of 78/100 (B+).

DELL

Strong Buy

75

out of 100

Grade: B+

Growth: 8.0Profit: 6.5Value: 8.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.61

LLY

Strong Buy

78

out of 100

Grade: B+

Growth: 10.0Profit: 10.0Value: 5.0Quality: 6.5
Piotroski: 6/9Altman Z: 2.06
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DELLUndervalued (+80.8%)

Margin of Safety

+80.8%

Fair Value

$644.85

Current Price

$211.64

$433.21 discount

UndervaluedFair: $644.85Overvalued

Intrinsic value data unavailable for LLY.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DELL6 strengths · Avg: 9.5/10
Return on EquityProfitability
44.3%10/10

Every $100 of equity generates 44 in profit

Revenue GrowthGrowth
39.5%10/10

Revenue surging 39.5% year-over-year

EPS GrowthGrowth
57.3%10/10

Earnings expanding 57.3% YoY

Debt/EquityHealth
-11.9210/10

Conservative balance sheet, low leverage

Market CapQuality
$136.65B9/10

Large-cap with strong market position

PEG RatioValuation
0.878/10

Growing faster than its price suggests

LLY6 strengths · Avg: 10.0/10
Market CapQuality
$862.01B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
101.2%10/10

Every $100 of equity generates 101 in profit

Profit MarginProfitability
35.0%10/10

Keeps 35 of every $100 in revenue as profit

Operating MarginProfitability
49.4%10/10

Strong operational efficiency at 49.4%

Revenue GrowthGrowth
55.5%10/10

Revenue surging 55.5% year-over-year

EPS GrowthGrowth
169.8%10/10

Earnings expanding 169.8% YoY

Areas to Watch

DELL2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

Profit MarginProfitability
5.2%3/10

5.2% margin — thin

LLY3 concerns · Avg: 3.0/10
P/E RatioValuation
34.3x4/10

Premium valuation, high expectations priced in

Debt/EquityHealth
1.603/10

Elevated debt levels

Price/BookValuation
32.6x2/10

Trading at 32.6x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : DELL

The strongest argument for DELL centers on Return on Equity, Revenue Growth, EPS Growth. Revenue growth of 39.5% demonstrates continued momentum. PEG of 0.87 suggests the stock is reasonably priced for its growth.

Bull Case : LLY

The strongest argument for LLY centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 35.0% and operating margin at 49.4%. Revenue growth of 55.5% demonstrates continued momentum.

Bear Case : DELL

The primary concerns for DELL are Altman Z-Score, Profit Margin.

Bear Case : LLY

The primary concerns for LLY are P/E Ratio, Debt/Equity, Price/Book. Debt-to-equity of 1.60 is elevated, increasing financial risk.

Key Dynamics to Monitor

DELL profiles as a hypergrowth stock while LLY is a growth play — different risk/reward profiles.

DELL carries more volatility with a beta of 1.06 — expect wider price swings.

LLY is growing revenue faster at 55.5% — sustainability is the question.

DELL generates stronger free cash flow (4.0B), providing more financial flexibility.

Bottom Line

LLY scores higher overall (78/100 vs 75/100), backed by strong 35.0% margins and 55.5% revenue growth. DELL offers better value entry with a 80.8% margin of safety. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Dell Technologies Inc

TECHNOLOGY · COMPUTER HARDWARE · USA

Dell Technologies Inc. designs, develops, manufactures, markets, sells and supports information technology solutions, products and services worldwide. The company is headquartered in Round Rock, Texas.

Visit Website →

Eli Lilly and Company

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.

Visit Website →

Want to dig deeper into these stocks?